Cyclin-Dependent Kinase Inhibitors and Human Cancer
Author:
- 1 January 1998
- book chapter
- Published by Springer Nature
- Vol. 227, 139-148
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomasMelanoma Research, 1995
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionNature, 1995
- Mutations associated with familial melanoma impair p16INK4 functionNature Genetics, 1995
- Loss of heterozygosity in sporadic primary cutaneous melanomaGenes, Chromosomes and Cancer, 1995
- p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21Cell, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Genetic alterations in bladder cancerThe Lancet, 1993
- Assignment of a Locus for Familial Melanoma, MLM, to Chromosome 9p13-p22Science, 1992